Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase. uri icon

authors

  • Tran, Arthur-Quan
  • Erim, Daniel O
  • Sullivan, Stephanie A
  • Cole, Ashley L
  • Emma Barber, MD, MS
  • Kim, Kenneth H
  • Gehrig, Paola A
  • Wheeler, Stephanie B

publication date

  • January 1, 2017